CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases. Our team has over 20 years’ experience in oncology and molecular cell biology and are using our expertise and experience in these areas to develop novel innovative treatments that will enhance the effectiveness of standard-of-care therapies in oncology and other inflammatory conditions.
CV6 Therapeutics is dedicated to the development of novel innovative therapeutics to enhance the effectiveness of the most widely used, standard-of-care therapies and to improve the lives of patients with cancer and inflammatory diseases.
Belfast, UK. 15th March, 2019. CV6 Therapeutics Inc., a drug development company focussed on the development and commercialisation of novel combination therapeutics for cancer and inflammatory diseases, today announced that CEO and Founder Dr Robert Ladner has been invited to participate in the Europe CEO networking forum in Vienna, Austria on the 24th of March, 2019. Europe CEO is […]Find Out More